L Agertoft
Overview
Explore the profile of L Agertoft including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
490
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bisgaard H, Pedersen S, Anhoj J, Agertoft L, Hedlin G, Gulsvik A, et al.
Respir Med
. 2007 Mar;
101(7):1477-82.
PMID: 17336509
Background: Asthma patients exhibit an increased rate of loss of lung function. Determinants to such decline are largely unknown and the modifying effect of steroid therapy is disputed. This cross-sectional...
2.
Petersen R, Agertoft L, Pedersen S
Eur Respir J
. 2004 Dec;
24(6):932-7.
PMID: 15572534
A new hydrofluoroalkane-beclomethasone dipropionate (HFA-BDP) aerosol markedly increases drug delivery to the airways. Therefore, even low doses of HFA-BDP should be effective, and the present study assesses this. A randomised,...
3.
Hansen B, Hoff B, Uldall P, Greisen G, Kamper J, Djernes B, et al.
Acta Paediatr
. 2004 Mar;
93(2):185-9.
PMID: 15046271
Aim: To investigate risk factors of adverse outcome in a cohort of very preterm children treated mainly with nasal continuous positive airway pressure (CPAP) during the neonatal course. Methods: In...
4.
Agertoft L, Laulund L, Harrison L, Pedersen S
Pediatr Pulmonol
. 2003 Feb;
35(3):192-9.
PMID: 12567387
We set out to evaluate lung deposition, systemic availability, and basic pharmacokinetic parameters of beclomethasone dipropionate (BDP) in children with chronic asthma. Plasma levels of BDP, 17 and 21 beclomethasone...
5.
Agertoft L, Pedersen S
Ugeskr Laeger
. 2002 Jan;
163(48):6746-50.
PMID: 11768900
Introduction: Short-term studies have shown that inhaled corticosteroids may retard the growth of children with asthma. The effect of long-term treatment on adult height is, however, uncertain. Material And Methods:...
6.
Agertoft L, Pedersen S
N Engl J Med
. 2000 Oct;
343(15):1064-9.
PMID: 11027740
Background: Short-term studies have shown that inhaled corticosteroids may reduce the growth of children with asthma. However, the effect of long-term treatment on adult height is uncertain. Methods: We conducted...
7.
Nikander K, Agertoft L, Pedersen S
J Asthma
. 2000 Sep;
37(5):451-9.
PMID: 10983623
The choice of patient-device interface (face mask or mouthpiece) influences the inhaled mass and the lung deposition of nebulized drugs. The use of a mouthpiece has been shown to double...
8.
Agertoft L, Pedersen S, Nikander K
J Aerosol Med
. 2000 Jan;
12(3):161-9.
PMID: 10623332
A total of 198 children aged 3 to 15 years inhaled a single dose of 200 micrograms budesonide from a Nebuhaler pressurized metered dose inhaler (pMDI) and a Turbuhaler dry...
9.
Agertoft L, Pedersen S
J Allergy Clin Immunol
. 1999 Nov;
104(5):948-52.
PMID: 10550737
Background: Mometasone furoate (MF) aqueous nasal spray is a potent intranasal glucocorticoid with low systemic bioavailability. Knemometry has been shown to be a sensitive method of detecting systemic effects of...
10.
Agertoft L, Andersen A, Weibull E, Pedersen S
Arch Dis Child
. 1999 May;
80(3):241-7.
PMID: 10325704
Aim: To evaluate the systemic availability and basic pharmacokinetic parameters of budesonide after nebulisation and intravenous administration in preschool children with chronic asthma. Methods: Plasma concentrations of budesonide were measured...